This is a non-core endpoint: only basic statistics are computed.
Sequelae of other and unspecified effects of external causes
ST19_SEQUEL_OTHER_UNSPE_EFFEC_EXTER_CAUSES1
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
237 |
4. Check minimum number of eventsNone |
237 |
5. Include endpointsNone |
237 |
6. Filter based on genotype QC (FinnGen only) |
209 |
Control definitions (FinnGen only)
- Control exclude
- ST19_SEQUEL_INJURI_POISO_OTHER_CONSE_EXTER_CAUSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T9
- Name in latin
- Sequelae effectuum causarum externarum aliarum sive non specificatarum
Similar endpoints
↥List of similar endpoints to
Sequelae of other and unspecified effects of external causes
based on the number of shared cases.
Similar with more cases:
- Sequelae of injuries, of poisoning and of other consequences of external causes
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 209 | 123 | 86 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 53.45 | 48.77 | 60.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 221
- Matched controls
- 2210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T98.3
ICD-10 Finland
Sequelae of complications of surgical and medical care, not elsewhere classified
+∞
179.6
147
*
T98.1
ICD-10 Finland
Sequelae of other and unspecified effects of external causes
+∞
43.1
40
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.8
28.5
44
68
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.8
27.7
30
29
N03AX16
ATC
[U] pregabalin
3.9
20.5
87
316
T98.0
ICD-10 Finland
Sequelae of effects of foreign body entering through natural orifice
+∞
20.1
19
*
X59
ICD-10 Finland
Exposure to unspecified factor
3.9
18.3
72
246
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.4
17.0
49
133
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
32.9
16.4
21
7
N02AX02
ATC
tramadol; systemic, rectal
3.2
15.9
128
668
N03AX12
ATC
[U] gabapentin; oral
3.6
15.8
65
227
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.1
15.2
28
51
WZC00
NOMESCO Finland
Treatment plan or consultation
2.9
13.8
111
568
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
13.4
47
146
ZXA05
NOMESCO Finland
Left side
3.1
13.1
75
316
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
12.1
12.9
23
21
R52.2
ICD-10 Finland
Other chronic pain
5.7
11.8
23
44
SAA04
NOMESCO Finland
Special examination of mouth
5.1
11.8
26
56
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
6.2
11.7
21
37
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
10.8
68
298
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
10.8
105
574
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.4
10.7
23
30
N06AX21
ATC
duloxetine; oral
3.3
10.3
44
154
N05BA01
ATC
diazepam; systemic, rectal
3.3
10.2
44
155
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
10.1
36
112
A06AC01
ATC
ispaghula (psylla seeds); oral
2.6
10.0
76
365
WX002
NOMESCO Finland
Sedation and analgesia
2.9
9.9
55
224
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
21.2
9.9
14
7
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
9.8
64
285
A02BC02
ATC
pantoprazole; systemic
2.8
9.7
171
1212
T98.2
ICD-10 Finland
Sequelae of certain early complications of trauma
+∞
9.4
9
*
H02AB06
ATC
prednisolone; systemic
2.4
9.3
125
775
N02BF02
ATC
pregabalin; oral
3.8
9.0
29
84
Z3231
NOMESCO Finland
Registered nurse
2.5
8.9
76
383
J01MA02
ATC
ciprofloxacin; systemic
2.3
8.7
103
601
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.9
8.3
19
42
K07.60
ICD-10 Finland
Snapping jaw
4.4
8.2
21
51
UKC02
NOMESCO Finland
Cystoscopy
2.9
8.1
44
176
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
8.0
85
469
N02BF01
ATC
gabapentin; oral
3.1
7.9
36
130
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.5
7.9
20
48
ZXD05
NOMESCO Finland
Urgent procedure
2.3
7.9
81
441
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
7.8
50
219
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
7.7
115
727
WX402
NOMESCO Finland
General anaesthesia
2.5
7.7
62
303
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
7.6
72
378
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.3
7.4
81
450
N03AF01
ATC
carbamazepine; oral, rectal
4.2
7.3
20
51
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.7
7.3
46
199
Z3226
NOMESCO Finland
Physiotherapist
2.5
7.2
51
233
N03AX09
ATC
lamotrigine; oral
4.0
7.1
21
57
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.2
7.1
19
48
AA1AD
NOMESCO Finland
CT of head and brain
2.3
7.0
72
389
R60.0
ICD-10 Finland
Localized oedema
2.9
7.0
35
134
XQ800
NOMESCO Finland
Prick test
3.5
6.9
25
78
ZY010
NOMESCO Finland
Hospital outpatient
3.8
6.9
22
63
N03AE01
ATC
clonazepam; systemic
4.0
6.8
20
54
J01DB01
ATC
cefalexin; oral
3.0
6.8
195
1583
R4110
NOMESCO Finland
Physiotherapy
2.2
6.7
72
395
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
6.6
45
202
J01FF01
ATC
clindamycin; systemic
2.2
6.6
72
398
M01AH05
ATC
etoricoxib; oral
2.2
6.5
153
1125
N06AB04
ATC
citalopram; systemic
2.3
6.5
56
280
RF211, ,
NOMESCO Finland
71.8
6.5
7
*
N05BA04
ATC
oxazepam; oral
2.2
6.3
70
387
R20.3
ICD-10 Finland
Hyperaesthesia
+∞
6.3
6
*
R51.81
ICD-10 Finland
Facial pain NOS
8.0
6.2
13
17
WYA10
NOMESCO Finland
Emergency care or similar visit
3.1
6.2
27
95
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
6.2
27
95
G44.2
ICD-10 Finland
Tension-type headache
2.5
6.2
44
201
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
2.8
6.1
34
137
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
6.1
68
377
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
141
895
2.59
10.41
4.0
2.9
—
—
estimate
—
0
0
87
452
2.53
9.72
2.6
2.2
2.37
2.85
mg/l
1.29
73
397
51
211
2.84
8.89
1.9
1.7
—
—
—
0
0
158
1113
2.47
8.51
11.1
10.3
4.25
4.12
e9/l
0.27
136
981
125
799
2.30
8.40
5.9
5.1
36.28
35.94
g/l
0.28
120
767
48
199
2.80
8.30
11.8
11.1
0.34
0.95
mmol/l
0.46
41
163
136
914
2.27
7.93
14.2
7.7
1.21
1.21
mmol/l
0.15
125
792
62
299
2.49
7.90
1.9
1.8
—
—
—
0
0
79
448
2.19
6.79
3.9
2.4
—
—
—
0
0
46
206
2.56
6.77
2.0
1.8
—
—
—
0
0
41
176
2.63
6.56
4.4
3.5
2.02
1.59
mmol/l
0.35
35
150
109
719
2.02
6.12
3.6
3.8
25.77
116.85
ng/l
0.56
75
481
51
253
2.32
5.97
10.6
7.1
104.51
104.20
mmol/l
0.18
51
253
94
593
2.02
5.94
2.0
2.2
145.33
205.81
u/l
0.97
87
565
182
1470
2.35
5.66
11.2
8.2
78.27
77.97
u/l
0.03
177
1393
85
527
2.00
5.57
1.8
1.6
21.54
20.60
nmol/l
0.23
78
455
15
40
3.95
5.18
2.6
1.4
—
—
—
0
0
111
769
1.89
5.12
2.6
2.0
99.55
95.25
pmol/l
0.41
62
402
20
66
3.23
5.09
1.3
1.2
—
—
—
0
0
26
101
2.78
5.01
5.0
2.9
24.22
24.28
mmol/l
0.04
26
101
85
545
1.91
4.93
4.2
2.9
0.29
0.40
e6/l
0.36
61
386
117
834
1.86
4.85
3.4
2.5
74.27
75.69
nmol/l
0.22
108
760
55
308
2.05
4.68
3.9
2.7
1.16
3.03
e6/l
1.54
26
148
30
131
2.49
4.61
1.6
1.5
—
—
—
0
0
82
536
1.84
4.39
3.7
3.4
1999.77
1246.95
ng/l
0.27
74
435
35
168
2.29
4.37
13.5
7.6
10.30
9.17
mmol/l
0.46
35
163
56
324
1.98
4.33
3.9
2.6
0.25
0.74
e6/l
2.75
28
164
90
619
1.77
3.99
3.0
2.7
859.95
69.57
u/l
0.49
85
580
10
19
5.46
3.87
2.2
1.3
—
—
—
0
0
49
283
1.94
3.78
1.9
1.6
1016.35
1238.57
nmol/l
1.06
37
213
131
1021
1.70
3.57
4.7
3.7
0.00
0.00
estimate
-0.00
22
222
167
1394
1.81
3.53
4.8
3.3
49.90
47.47
u/l
0.16
160
1324
22
95
2.46
3.47
1.6
1.6
—
—
—
0
0
69
458
1.74
3.37
2.3
1.7
1.26
1.18
mg/l
0.08
53
365
13
39
3.48
3.28
1.8
1.3
—
—
—
0
0
96
704
1.64
3.20
4.7
3.2
32.06
33.30
u/l
0.11
84
670
130
1030
1.64
3.17
4.8
3.7
0.00
0.00
estimate
-0.00
22
225
9
20
4.64
3.15
2.2
1.5
—
—
—
0
0
54
342
1.77
3.08
5.4
3.6
849.70
315.72
ng/l
0.28
37
258
131
1044
1.63
3.08
5.0
3.7
0.00
0.00
estimate
-0.00
20
209
58
376
1.74
3.05
1.3
1.3
15.86
27.39
iu/ml
1.37
17
131
117
910
1.61
3.02
4.2
3.1
99.82
113.94
ug/l
0.53
112
864
54
347
1.74
2.92
1.2
1.3
1.07
8.38
u/ml
2.60
23
141
22
103
2.26
2.92
3.2
2.5
1.55
1.15
%
0.64
22
103
16
67
2.50
2.70
1.7
1.5
—
—
—
0
0
173
1502
1.70
2.69
4.8
4.4
14.54
14.67
pmol/l
0.29
162
1381
32
180
1.91
2.65
3.2
3.4
—
—
—
0
0
207
1907
2.35
2.57
28.1
15.0
23.20
23.16
mg/l
0.00
190
1548
86
650
1.53
2.37
4.4
3.5
2.34
2.35
mmol/l
0.19
78
598
21
106
2.08
2.34
4.9
3.2
130.94
196.35
ng/l
0.64
16
95
20
101
2.08
2.23
3.0
2.5
0.58
0.61
%
0.21
20
101
52
355
1.61
2.21
2.4
2.9
2.43
2.45
mmol/l
0.55
45
319
13
55
2.45
2.16
2.1
1.6
—
—
—
0
0
5
10
5.09
2.08
11.0
2.4
98.60
93.80
%
—
5
10
17
83
2.14
2.07
2.8
4.0
24.56
24.36
mmol/l
0.09
17
78
64
468
1.52
2.01
6.0
3.7
1.02
1.02
kg/l
1.48
48
310
199
1838
1.83
1.97
25.5
14.0
82.45
83.64
ml/min/173m2
0.32
185
1694
9
34
2.72
1.88
1.0
1.1
—
—
—
0
0
66
492
1.49
1.88
3.2
2.9
355.80
341.96
umol/l
0.44
60
441
12
55
2.25
1.70
1.0
1.5
—
—
—
0
0
192
1778
1.61
1.59
6.1
5.3
1.73
1.89
mu/l
0.86
181
1659
7
27
2.64
1.52
1.1
1.6
—
—
—
0
0
28
180
1.64
1.52
3.1
4.5
12.13
31.73
ug/l
0.36
20
147
142
1249
1.38
1.50
3.5
3.3
—
—
—
0
0
13
66
2.03
1.46
2.7
2.4
—
—
—
0
0
26
166
1.64
1.45
1.5
1.4
—
—
—
0
0
24
152
1.65
1.39
1.8
2.1
—
—
—
0
0
6
23
2.65
1.37
1.3
1.2
—
—
—
0
0
37
261
1.50
1.37
1.8
1.8
1.57
1.49
%
0.29
27
230
11
54
2.09
1.35
2.3
2.0
1.55
4.98
iu/l
—
5
21
27
178
1.59
1.34
5.0
2.6
0.25
0.23
g/l
0.77
27
167
21
130
1.68
1.32
1.6
2.0
—
—
—
0
0
6
24
2.54
1.31
1.0
1.5
—
—
—
0
0
5
18
2.82
1.29
1.0
1.1
—
—
—
0
0
6
25
2.44
1.25
1.0
1.5
—
—
—
0
0
6
25
2.44
1.25
1.0
1.5
—
—
—
0
0
13
71
1.88
1.22
1.4
2.1
—
—
—
0
0
5
19
2.67
1.22
1.0
1.2
—
—
—
0
0
23
150
1.60
1.20
1.4
1.2
137.48
304.65
u/ml
0.51
23
136
10
50
2.05
1.18
1.5
1.2
—
—
—
0
0
8
39
2.09
1.16
1.3
1.5
—
—
—
0
0
8
39
2.09
1.16
1.3
1.5
—
—
—
0
0
5
20
2.53
1.15
1.0
1.2
—
—
—
0
0
8
41
1.99
1.10
1.3
1.5
—
—
—
0
0
9
46
2.00
1.05
2.2
1.6
—
—
—
0
0
62
507
1.31
0.99
1.4
1.3
0.93
1.32
u/ml
0.46
16
143
9
50
1.83
0.98
1.2
1.2
—
—
—
0
0
71
594
1.29
0.95
3.2
3.1
0.00
0.02
estimate
1.08
13
179
12
70
1.76
0.94
1.2
1.2
—
—
—
0
0
188
1778
1.38
0.94
7.3
6.1
38.49
39.18
mmol/mol
0.60
179
1691
10
55
1.86
0.93
1.1
1.3
—
—
—
0
0
33
249
1.38
0.88
1.9
2.1
—
—
—
0
0
36
276
1.36
0.88
2.0
2.2
—
—
—
0
0
18
121
1.53
0.86
1.3
1.4
—
—
—
0
0
94
827
1.24
0.81
2.1
2.0
1.42
1.40
mmol/l
0.11
78
702
27
202
1.38
0.77
7.5
6.8
—
—
—
0
0
0
28
0.00
0.76
0.0
4.3
—
—
—
0
0
29
220
1.37
0.76
4.5
4.3
34.44
32.12
%
0.40
16
146
7
38
1.87
0.74
2.3
2.0
—
—
—
0
0
12
76
1.61
0.73
1.3
1.4
167.91
279.09
miu/ml
—
7
39
5
25
2.02
0.73
1.0
1.5
—
—
—
0
0
5
25
2.02
0.73
2.0
3.2
105.60
106.56
mmol/l
—
5
25
5
25
2.02
0.73
2.0
3.2
1.18
1.19
mmol/l
—
5
25
9
57
1.60
0.72
1.0
1.5
—
—
—
0
0
5
26
1.94
0.71
1.0
1.5
—
—
—
0
0
5
26
1.94
0.71
1.4
1.3
—
—
—
0
0
5
26
1.94
0.71
1.0
1.5
—
—
—
0
0
13
85
1.56
0.70
2.4
1.8
—
—
—
0
0
11
69
1.63
0.69
1.3
1.2
—
—
—
0
0
11
69
1.63
0.69
1.5
1.9
—
—
—
0
0
19
136
1.43
0.69
2.5
2.6
19.20
5.62
ug/l
0.40
14
121
90
800
1.21
0.68
4.7
3.6
0.00
0.00
estimate
-0.00
15
183
20
146
1.41
0.66
2.8
2.4
66.00
66.75
ml/min/173m2
0.03
12
65
0
20
0.00
0.60
0.0
1.1
—
8.52
—
0
9
8
52
1.56
0.60
1.0
1.4
—
—
—
0
0
6
36
1.68
0.57
2.3
3.3
168.83
37.53
u/ml
—
6
36
6
36
1.68
0.57
2.3
1.6
—
—
—
0
0
44
370
1.24
0.57
2.0
1.8
467.18
440.84
pmol/l
0.22
38
320
9
62
1.47
0.54
5.0
2.6
25.21
25.18
mmol/l
—
9
62
55
481
1.19
0.49
4.1
4.6
24.48
22.32
%
0.26
22
229
68
608
1.17
0.47
6.2
5.1
2.24
1.99
ug/l
0.32
57
548
43
371
1.20
0.44
3.0
3.1
0.77
0.78
ug/l
0.02
20
222
65
584
1.16
0.42
5.3
3.8
0.00
0.00
estimate
-0.00
21
207
0
15
0.00
0.41
0.0
1.3
—
8.20
—
0
15
5
34
1.48
0.40
1.0
1.4
—
—
—
0
0
5
35
1.44
0.39
2.2
1.6
56.32
53.17
ug/l
—
5
35
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
6
42
1.44
0.36
1.0
1.4
—
—
—
0
0
21
176
1.21
0.30
1.6
1.8
3.83
3.57
mmol/l
0.22
12
132
192
1880
1.16
0.27
5.7
5.0
4.63
4.69
mmol/l
0.31
181
1768
66
611
1.11
0.27
4.6
4.0
8.27
11.02
mg/mmol
0.38
40
404
28
247
1.15
0.24
2.0
2.0
3.86
3.51
ratio
0.56
20
204
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
11
89
1.25
0.21
1.1
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
111.65
—
0
13
0
13
0.00
0.21
0.0
3.2
—
1.15
—
0
13
35
318
1.12
0.20
1.5
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
6
52
1.16
0.19
1.3
1.3
—
43.90
—
0
10
187
1839
1.11
0.18
5.5
4.8
5.82
5.89
mmol/l
0.45
179
1711
190
1872
1.11
0.16
5.5
4.9
1.41
1.46
mmol/l
1.07
176
1751
9
79
1.15
0.15
1.7
1.4
—
—
—
0
0
183
1805
1.08
0.13
4.7
4.2
1.38
1.28
mmol/l
0.83
169
1679
5
47
1.07
0.09
1.4
1.7
—
—
—
0
0
7
67
1.05
0.08
1.1
1.1
—
2.97
—
0
9
6
75
0.79
0.07
2.0
1.4
—
—
—
0
0
7
84
0.83
0.07
1.0
1.1
1.48
1.54
g/l
—
7
84
9
85
1.06
0.07
1.8
1.1
1.03
0.92
g/l
—
9
85
13
142
0.91
0.06
2.1
3.6
1.23
1.22
mmol/l
0.14
13
118
42
408
1.04
0.04
1.8
1.6
—
—
—
0
0
13
121
1.08
0.04
1.0
1.1
—
—
—
0
0
191
1908
1.01
0.00
6.3
5.6
2.65
2.75
mmol/l
0.73
177
1792
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
8
85
0.94
-0.00
1.8
1.8
31.12
39.55
nmol/l
—
8
85
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
5
58
0.86
-0.00
1.2
1.1
—
5.64
—
0
11
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
0.20
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
18.95
—
0
8
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
38.36
—
0
5
5
49
1.02
-0.00
1.8
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_SEQUEL_OTHER_UNSPE_EFFEC_EXTER_CAUSES1 – Sequelae of other and unspecified effects of external causes
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).